<SEC-DOCUMENT>0001213900-21-037808-index.html : 20210721 <SEC-HEADER>0001213900-21-037808.hdr.sgml : 20210721 <ACCEPTANCE-DATETIME>20210720202321 ACCESSION NUMBER: 0001213900-21-037808 CONFORMED SUBMISSION TYPE: S-1/A PUBLIC DOCUMENT COUNT: 11 FILED AS OF DATE: 20210721 DATE AS OF CHANGE: 20210720 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ABVC BIOPHARMA, INC. CENTRAL INDEX KEY: 0001173313 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260014658 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-1/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-255112 FILM NUMBER: 211102404 BUSINESS ADDRESS: STREET 1: 44370 OLD WARM SPRINGS BLVD. CITY: FREMONT STATE: CA ZIP: 94538 BUSINESS PHONE: 510-668-0881 MAIL ADDRESS: STREET 1: 44370 OLD WARM SPRINGS BLVD. CITY: FREMONT STATE: CA ZIP: 94538 FORMER COMPANY: FORMER CONFORMED NAME: American BriVision (Holding) Corp DATE OF NAME CHANGE: 20160111 FORMER COMPANY: FORMER CONFORMED NAME: METU BRANDS, INC. DATE OF NAME CHANGE: 20150908 FORMER COMPANY: FORMER CONFORMED NAME: ECOLOGY COATINGS, INC. DATE OF NAME CHANGE: 20080821 </SEC-HEADER> <DOCUMENT> <TYPE>S-1/A <SEQUENCE>1 <FILENAME>ea144504-s1a3_abvcbiopharma.htm <DESCRIPTION>AMENDMENT NO. 3 TO FORM S-1 <TEXT> Document 1 - file: ea144504-s1a3_abvcbiopharma.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-1.1 <SEQUENCE>2 <FILENAME>ea144504ex1-1_abvcbiopharma.htm <DESCRIPTION>FORM OF UNDERWRITING AGREEMENT <TEXT> Document 2 - file: ea144504ex1-1_abvcbiopharma.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.3 <SEQUENCE>3 <FILENAME>ea144504ex4-3_abvcbiopharma.htm <DESCRIPTION>FORM OF REPRESENTATIVE'S WARRANT <TEXT> Document 3 - file: ea144504ex4-3_abvcbiopharma.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.5 <SEQUENCE>4 <FILENAME>ea144504ex4-5_abvcbiopharma.htm <DESCRIPTION>FORM OF LOCK-UP AGREEMENT <TEXT> Document 4 - file: ea144504ex4-5_abvcbiopharma.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.2 <SEQUENCE>5 <FILENAME>ea144504ex23-2_abvcbiopharma.htm <DESCRIPTION>CONSENT OF KCCW ACCOUNTANCY CORP <TEXT> Document 5 - file: ea144504ex23-2_abvcbiopharma.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>image_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: image_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>image_002.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 7 - file: image_002.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>8 <FILENAME>image_003.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 8 - file: image_003.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>9 <FILENAME>image_004.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 9 - file: image_004.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>10 <FILENAME>image_005.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 10 - file: image_005.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>11 <FILENAME>ex23-2_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 11 - file: ex23-2_001.jpg
</DOCUMENT> </SEC-DOCUMENT>